Brief: Grand Pharmaceutical Group Enters Into An Equity Investment Agreement
12/12/2023 17:01
Dec 12 (Reuters) - Grand Pharmaceutical Group Ltd
0512.HK :
* GROUP ENTERS INTO AN EQUITY INVESTMENT AGREEMENT WITH
DUOPUTAI
PHARMACEUTICAL
* XI'AN BEILIN PHARMACEUTICAL WILL ACQUIRE 27% STAKE OF
CHONGQING
DUOPUTAI PHARMACEUTICAL TECHNOLOGY
* DEAL FOR RMB189.54 MILLION
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement